References
- Pell MT. Rosacea. In: Goldsmith LA, Katz SI, Gilchrest BA, et al., editors. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw- Hill, 2012. p. 918–925.
- Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51(3):327–341.
- Two AM, Wu W, Gallo RL, et al. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 2015;72(5):749–758 (quiz 759–760).
- Powell FC. Clinical practice. Rosacea. N Engl J Med. 2005;352(8):793–803.
- Bikowski J. Rosacea regimens. In: Draelos ZD, editor. Cosmetic dermatology: products and procedures. Vol. 61. Hohoken, NJ: Wiley-Blackwell; 2010. p. 495–501.
- Cardwell LA, Alinia H, Tuchayi SM, et al. New developments in the treatment of rosacea – role of once-daily ivermectin cream. Clin Cosmet Investig Dermatol. 2016;9:71–77.
- Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002;46(4):584–587.
- Jafari AK, Akhyani M, Ehsani AH, et al. Correlation of the severity of cutaneous rosacea with ocular rosacea. Indian J Dermatol Venereol Leprol. 2009;75(4):405–406.
- Su D, Drummond PD. Blushing propensity and psychological distress in people with rosacea. Clin Psychol Psychother. 2012;19(6):488–495.
- Bard S, Goldberg DJ. Laser treatment of vascular lesions. Aesthet Dermatol. 2014;1:40–65.
- Harto A, Garcia-Morales I, Belmar P, et al. Pulsed dye laser treatment of acne. Study of clinical efficacy and mechanism of action. Actas Dermosifiliogr. 2007;98(6):415–419.
- Seaton ED, Mouser PE, Charakida A, et al. Investigation of the mechanism of action of nonablative pulsed‐dye laser therapy in photorejuvenation and inflammatory acne vulgaris. Br J Dermatol. 2006;155(4):748–755.
- Napierkowski DB. Rosacea: diagnosis and management. Nurse Practitioner. 2016;41(4):8–13.
- Forton F. Papulopustular rosacea, skin immunity and Demodex: pityriasis folliculorum as a missing link. J Eur Acad Dermatol Venereol. 2012;26(1):19–28.
- Stein L, Kircik L, Fowler J, et al. Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies. J Drugs Dermatol. 2014;13(3):316–323.
- Abokwidir M, Fleischer AB. An emerging treatment: topical ivermectin for papulopustular rosacea. J Dermatolog Treat. 2015;26(4):379–380.
- Wolstenholme AJ, Rogers AT. Glutamate-gated chloride channels and the mode of action of the avermectin/milbemycin anthelmintics. Parasitology. 2006;131(S1):S85–S95.
- Tan ST, Bialostocki A, Armstrong JR. Pulsed dye laser therapy for rosacea. Int J Surg Reconstr. 2004;57:303–310.
- Bernstein EF, Kligman A. Rosacea treatment using the new-generation, high-energy, 595 nm, long pulse-duration pulsed-dye laser. Lasers Surg Med. 2008;40(4):233–239.
- Bernstein EF, Schomacker K, Paranjape A, et al. Pulsed dye laser treatment of rosacea using a novel 15mm diameter treatment beam. Lasers Surg Med. 2018;50(8):808–812.
- Taieb A, Ortonne JP, Ruzicka T, et al. the Ivermectin Phase III study group. Superiority of ivermectin 1% cream over metronidazole 0⋅75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial. Br J Dermatol. 2015;172(4):1103–1110.
- Schaller M, Gonser L, Belge K, et al. Dual anti-inflammatory and anti-parasitic action of topical ivermectin 1% in papulopustular rosacea. J Eur Acad Dermatol Venereol. 2017;31:1907–1911.
- Lallas A, Argenziano G, Apalla Z, et al. Dermoscopic patterns of common facial inflammatory skin diseases. J Eur Acad Dermatol Venereol . 2014;28:609–614.
- Lallas A, Argenziano G, Longo C, et al. Polygonal vessels of rosacea are highlighted by dermoscopy. Int J Dermatol. 2014;53(5):e325–331.